Zobrazeno 1 - 10 of 16 pro vyhledávání: '"J B, Piper"'
2
Reversal of accelerated renal allograft rejection with FK 506
Autor: E S, Woodle, K A, Newell, M, Haas, S, Bartosh, M A, Josephson, J M, Millis, D S, Bruce, J B, Piper, A J, Aronson, J R, Thistlethwaite
Publikováno v: Clinical transplantation. 11(4)
Although FK 506 has been shown to effectively reverse refractory renal allograft rejection, its ability to reverse accelerated renal allograft rejection as a primary agent has not been specifically addressed. Herein evidence of the ability of FK 506
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::8077eeadd8e7a34f9f7121d03f0836e0
https://pubmed.ncbi.nlm.nih.gov/9267710
Zobrazit plný text záznamu
4
Portal vein thrombosis and stenosis in pediatric liver transplantation
Autor: J M, Millis, D S, Seaman, J B, Piper, E M, Alonso, S, Kelly, C A, Hackworth, K A, Newell, D S, Bruce, E S, Woodle, J R, Thistlethwaite, P F, Whitington
Publikováno v: Transplantation. 62(6)
The aim of this study was to determine the outcome of venous conduits used in living donor liver transplantation (LDLT). We analyzed the portal vein complications in 66 LDLT recipients and 48 cadaveric reduced-size liver transplant (RLT) recipients p
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::ce719a6f3d9c7639258fec1e26b95d02
https://pubmed.ncbi.nlm.nih.gov/8824471
Zobrazit plný text záznamu
5
FK 506 therapy for refractory renal allograft rejection: lessons from liver transplantation
Autor: E S, Woodle, D S, Bruce, M, Josephson, K A, Newell, J B, Piper, J M, Millis, D, Cronin, G, Whitman, M, Ruebe, J R, Thistlethwaite
Publikováno v: Clinical transplantation. 10(4)
FK 506 has proven to be an effective immunosuppressive agent in liver transplantation, but its role in renal transplantation remains to be defined. Since the initial availability of FK 506 for treatment of refractory renal allograft rejection, we hav
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::efdc015b12a19acee6a63efd9c1fd98d
https://pubmed.ncbi.nlm.nih.gov/8884103
Zobrazit plný text záznamu
6
OKT3 escalating dose regimens provide effective therapy for renal allograft rejection
Autor: E S, Woodle, D S, Bruce, M, Josephson, D, Cronin, K A, Newell, J M, Millis, J B, Piper, R, O'Laughlin, J R, Thistlethwaite
Publikováno v: Clinical transplantation. 10(4)
Dose-response relationships for anti-CD3 monoclonal antibody (mAb) therapy remain undefined, particularly with respect to higher dose ranges. The clinical efficacy and safety of an OKT3 dosing regimen that incorporates higher doses (escalating dose r
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::4b9e3b7f63c420f3e90b0ea48e92b455
https://pubmed.ncbi.nlm.nih.gov/8884115
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje